The Peptide YY-Preferring Receptor Mediating Inhibition of Small Intestinal Secretion Is a Peripheral Y2Receptor: Pharmacological Evidence and Molecular Cloning
Authors:
- Thierry VoisinTVThierry Voisin
- Anne-Marie LorinetALAnne-Marie Lorinet
- Robert DucrocRDRobert Ducroc
- Annick TsocasATAnnick Tsocas
- Claude RozéCRClaude Rozé
- Patricia Rouet-BenzinebPRPatricia Rouet-Benzineb
- Herbert HerzogHHHerbert Herzog
- Ambikaipakan BalasubramaniamABAmbikaipakan Balasubramaniam
- Marc LaburtheMLMarc Laburthe
- 1 July 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (1) , 124-134
Abstract
A peptide YY (PYY)-preferring receptor [PYY > neuropeptide Y (NPY)] was previously characterized in rat small intestinal crypt cells, where it mediates inhibition of fluid secretion. Here, we investigated the possible status of this receptor as a peripheral Y2 receptor in rats. Typical Y2 agonists (PYY3–36, NPY3–36, NPY13–36, C2-NPY) and very short PYY analogs (N-α-Ac-PYY22–36 andN-α-Ac-PYY25–36) acting at the intestinal PYY receptor were tested for their ability to inhibit the binding of125I-PYY to membranes of rat intestinal crypt cells and of CHO cells stably transfected with the rat hippocampal Y2 receptor cDNA. Similar PYY preference was observed and all analogs exhibited comparable high affinity in both binding assays. The same held true for the specific Y2 antagonist BIIE0246 with a Ki value of 6.5 and 9.0 nM, respectively. BIIE0246 completely abolished the inhibition of cAMP production by PYY in crypt cells and transfected CHO cells. Moreover, the antagonist 1) considerably reversed the PYY-induced reduction of short-circuit current in rat jejunum mucosa in Ussing chamber and 2) completely abolished the antisecretory action of PYY on vasoactive intestinal peptide (VIP)-induced fluid secretion in rat jejunum in vivo. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) experiments showed that Y2 receptor transcripts were present in intestinal crypt cells (3 × 102molecules/100 ng RNAT) with no expression in villus cells, in complete agreement with the exclusive binding of PYY in crypt cells. Finally, a full-length Y2 receptor was cloned by RT-PCR from rat intestinal crypt cells and also from human small intestine. We conclude that the so-called PYY-preferring receptor mediating inhibition of intestinal secretion is a peripheral Y2receptor.Keywords
This publication has 45 references indexed in Scilit:
- Structure−Activity Studies Including a Ψ(CH2-NH) Scan of Peptide YY (PYY) Active Site, PYY(22−36), for Interaction with Rat Intestinal PYY Receptors: Development of Analogues with Potent in Vivo Activity in the IntestineJournal of Medicinal Chemistry, 2000
- BIIE0246, a potent and highly selective non‐peptide neuropeptide Y Y2 receptor antagonistBritish Journal of Pharmacology, 2000
- PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epitheliaCanadian Journal of Physiology and Pharmacology, 2000
- Identification and Distribution of mRNA Encoding the Y1, Y2, Y4, and Y5 Receptors for Peptides of the PP-fold Family in the Rat Intestine and ColonBiochemical and Biophysical Research Communications, 1998
- Y-receptor subtypes—how many more?Trends in Neurosciences, 1997
- Comparison of the Antisecretory Effect of Endogenous Forms of Peptide YY on Fed and Fasted Rat JejunumPeptides, 1997
- Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasisTrends in Pharmacological Sciences, 1996
- Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YYJournal of Biological Chemistry, 1995
- Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor SubtypeJournal of Biological Chemistry, 1995
- Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y ReceptorJournal of Biological Chemistry, 1995